MyAverix Finance
TWO · Healthcare
Mycenax Biotech (4726)
Biotechnology
Mycenax Biotech (4726) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4726
Mycenax Biotech (4726) — FAQ
What is 4726's P/E ratio?
The price-to-earnings (P/E) ratio for Mycenax Biotech (4726) is 25.00 (data as of 2026-05-23).
Does Mycenax Biotech pay a dividend?
Dividend yield is not available in the current snapshot for Mycenax Biotech (4726). Check the MyAverix Finance app for the latest dividend data.
What sector is Mycenax Biotech in?
Mycenax Biotech (4726) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4726 listed on?
4726 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.